Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort

The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of HIV viremia in patients living with HIV (PLWH) who switch to two-drug antiretroviral therapy (2DR) containing lamivudine (3TC) (2DR-3TC-based). A retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Malagnino, Vincenzo, Salpini, Romina, Teti, Elisabetta, Compagno, Mirko, Ferrari, Ludovica, Mulas, Tiziana, Svicher, Valentina, Zordan, Marta, Basso, Monica, Battagin, Giuliana, Panese, Sandro, Rossi, Maria Cristina, Scaggiante, Renzo, Zago, Daniela, Iannetta, Marco, Parisi, Saverio Giuseppe, Andreoni, Massimo, Sarmati, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860946/
https://www.ncbi.nlm.nih.gov/pubmed/36680233
http://dx.doi.org/10.3390/v15010193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860946/
https://www.ncbi.nlm.nih.gov/pubmed/36680233
http://dx.doi.org/10.3390/v15010193

Ejemplares similares